Charles Duyckaerts

40.8k total citations · 7 hit papers
287 papers, 21.6k citations indexed

About

Charles Duyckaerts is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Charles Duyckaerts has authored 287 papers receiving a total of 21.6k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Physiology, 91 papers in Molecular Biology and 90 papers in Neurology. Recurrent topics in Charles Duyckaerts's work include Alzheimer's disease research and treatments (134 papers), Parkinson's Disease Mechanisms and Treatments (56 papers) and Dementia and Cognitive Impairment Research (39 papers). Charles Duyckaerts is often cited by papers focused on Alzheimer's disease research and treatments (134 papers), Parkinson's Disease Mechanisms and Treatments (56 papers) and Dementia and Cognitive Impairment Research (39 papers). Charles Duyckaerts collaborates with scholars based in France, United States and United Kingdom. Charles Duyckaerts's co-authors include Étienne C. Hirsch, Marie‐Claude Potier, Benoı̂t Delatour, Jean‐Jacques Hauw, Dennis W. Dickson, Suzanne S. Mirra, Nigel J. Cairns, Bradley T. Hyman, John Q. Trojanowski and Thomas G. Beach and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Charles Duyckaerts

282 papers receiving 21.2k citations

Hit Papers

National Institute on Aging–Alzhe... 1992 2026 2003 2014 2012 2011 2008 2004 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
    2012 2.1k citations Charles Duyckaerts et al. profile →
  2. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
    2011 1.9k citations Charles Duyckaerts et al. Acta Neuropathologica profile →
  3. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease
    2008 937 citations Charles Duyckaerts et al. profile →
  4. Dopamine depletion impairs precursor cell proliferation in Parkinson disease
    2004 752 citations Charles Duyckaerts et al. profile →
  5. Classification and basic pathology of Alzheimer disease
    2009 749 citations Charles Duyckaerts, Marie‐Claude Potier et al. Acta Neuropathologica profile →
  6. Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration
    2002 503 citations Charles Duyckaerts et al. profile →
  7. The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke
    1992 393 citations Charles Duyckaerts, Christophe Tzourio et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Duyckaerts France 72 9.5k 6.6k 6.6k 5.5k 4.6k 287 21.6k
Thomas J. Montine United States 86 10.8k 1.1× 8.7k 1.3× 6.7k 1.0× 3.7k 0.7× 5.2k 1.1× 439 27.1k
Paul G. Ince United Kingdom 80 6.3k 0.7× 5.5k 0.8× 9.2k 1.4× 3.7k 0.7× 5.1k 1.1× 295 21.7k
Nigel J. Cairns United States 58 8.5k 0.9× 5.4k 0.8× 6.8k 1.0× 2.7k 0.5× 3.4k 0.7× 181 17.6k
Juan C. Troncoso United States 87 9.5k 1.0× 11.3k 1.7× 7.3k 1.1× 6.6k 1.2× 4.0k 0.9× 318 26.0k
Dietmar Rudolf Thal Germany 60 11.5k 1.2× 5.1k 0.8× 5.0k 0.8× 2.7k 0.5× 4.6k 1.0× 234 19.1k
Jeffery M. Vance United States 70 10.3k 1.1× 12.8k 1.9× 4.2k 0.6× 7.0k 1.3× 3.6k 0.8× 298 29.0k
Peter Davies United States 80 14.0k 1.5× 8.4k 1.3× 4.2k 0.6× 5.9k 1.1× 4.5k 1.0× 232 22.9k
Lawrence A. Hansen United States 70 10.4k 1.1× 4.6k 0.7× 4.0k 0.6× 5.2k 0.9× 3.4k 0.7× 170 18.6k
Stephen W. Scheff United States 75 7.0k 0.7× 6.5k 1.0× 4.1k 0.6× 6.4k 1.1× 3.4k 0.7× 184 20.0k
Irina Alafuzoff Sweden 61 6.9k 0.7× 4.4k 0.7× 3.8k 0.6× 3.8k 0.7× 2.6k 0.6× 205 14.2k

Countries citing papers authored by Charles Duyckaerts

Since Specialization
Citations

This map shows the geographic impact of Charles Duyckaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Duyckaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Duyckaerts more than expected).

Fields of papers citing papers by Charles Duyckaerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Duyckaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Duyckaerts. The network helps show where Charles Duyckaerts may publish in the future.

Co-authorship network of co-authors of Charles Duyckaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Duyckaerts. A scholar is included among the top collaborators of Charles Duyckaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Duyckaerts. Charles Duyckaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leroy, Karelle, Fanny Lalloyer, Eric Baugé, et al.. (2021). Regulation of PPARα by APP in Alzheimer disease affects the pharmacological modulation of synaptic activity. JCI Insight. 6(16). 16 indexed citations
2.
Codron, Philippe, Franck Letournel, Serge Marty, et al.. (2020). STochastic Optical Reconstruction Microscopy (STORM) reveals the nanoscale organization of pathological aggregates in human brain. Neuropathology and Applied Neurobiology. 47(1). 127–142. 28 indexed citations
3.
Ando, Kunié, Robert De Decker, Cristina Vergara, et al.. (2020). Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathologica. 139(4). 773–789. 34 indexed citations
4.
Barnat, Monia, Mariacristina Capizzi, Radhia Kacher, et al.. (2020). Huntington’s disease alters human neurodevelopment. Science. 369(6505). 787–793. 188 indexed citations
5.
6.
Bielle, Franck, Chiara Villa, Marine Giry, et al.. (2015). Chordoid Gliomas of the Third Ventricle Share TTF-1 Expression With Organum Vasculosum of the Lamina Terminalis. The American Journal of Surgical Pathology. 39(7). 948–956. 41 indexed citations
7.
Allenbach, Yves, Wahiba Chaara, Michèlle Rosenzwajg, et al.. (2014). Th1 Response and Systemic Treg Deficiency in Inclusion Body Myositis. PLoS ONE. 9(3). e88788–e88788. 61 indexed citations
8.
Desestret, Virginie, Nathalie Streichenberger, Muriel Panouillères, et al.. (2013). An Elderly Woman With Difficulty Reading and Abnormal Eye Movements. Journal of Neuro-Ophthalmology. 33(3). 296–301. 2 indexed citations
9.
Bouleti, Claire, Thomas Mathivet, Bérard Coqueran, et al.. (2013). Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. European Heart Journal. 34(47). 3657–3668. 61 indexed citations
10.
Seilhean, Danielle, Cécile Cazeneuve, Stéphanie Millecamps, et al.. (2009). Accumulation of TDP-43 and α-actin in an amyotrophic lateral sclerosis patient with the K17I ANG mutation. Acta Neuropathologica. 118(4). 561–573. 57 indexed citations
11.
Sparaco, Marco, Laura Gaeta, Filippo M. Santorelli, et al.. (2009). Friedreich's ataxia: Oxidative stress and cytoskeletal abnormalities. Journal of the Neurological Sciences. 287(1-2). 111–118. 70 indexed citations
12.
Boddaert, Jacques, Kiyoka Kinugawa, Jean‐Charles Lambert, et al.. (2007). Evidence of a Role for Lactadherin in Alzheimer's Disease. American Journal Of Pathology. 170(3). 921–929. 83 indexed citations
13.
Zekry, Dina, et al.. (2002). Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathologica. 103(5). 481–487. 142 indexed citations
14.
Caparros-Lefèbvre, D, Nicolas Sergeant, Andrew J. Lees, et al.. (2002). Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy‐like tauopathy. Brain. 125(4). 801–811. 109 indexed citations
15.
Zekry, Dina, Charles Duyckaerts, Joël Belmin, et al.. (2002). The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiology of Aging. 24(2). 213–219. 76 indexed citations
16.
Duyckaerts, Charles, et al.. (2001). Les associations de malades et les banques de tissus. Bulletin de l Académie Nationale de Médecine. 185(5). 857–866. 2 indexed citations
17.
Uchihara, Toshiki, Charles Duyckaerts, Yi He, et al.. (1995). ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neuroscience Letters. 195(1). 5–8. 99 indexed citations
18.
Duyckaerts, Charles, et al.. (1992). The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke. New England Journal of Medicine. 326(4). 221–225. 393 indexed citations breakdown →
19.
Gray, F, et al.. (1992). [Gerstmann-Sträussler-Scheinker disease. Pathologal and genetic study].. PubMed. 148(5). 335–42. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas J. Montine Breakdown of academic impact, for papers by Paul G. Ince Breakdown of academic impact, for papers by Nigel J. Cairns Breakdown of academic impact, for papers by Juan C. Troncoso Breakdown of academic impact, for papers by Dietmar Rudolf Thal Breakdown of academic impact, for papers by Jeffery M. Vance Breakdown of academic impact, for papers by Peter Davies Breakdown of academic impact, for papers by Lawrence A. Hansen Breakdown of academic impact, for papers by Stephen W. Scheff Breakdown of academic impact, for papers by Irina Alafuzoff
Rankless by CCL
2026